ÌÇÐÄÆÆ½â°æ

Pharmaceutical research and development

Statistics report about R&D in the pharmaceutical industry

This report presents key facts and figures about research and development in the pharmaceutical industry worldwide. The pharmaceutical industry is one of the segments most driven by innovation through research and development investments. This report gives you an overview about pharmaceutical R&D in general, the top companies, characteristics of the current R&D pipeline, and many more.

Table of contents

Market overview & investment trends

3
  • Premium Statistic Total global pharmaceutical R&D spending 2016-2030
  • Premium Statistic R&D spending growth worldwide on pharmaceuticals 2019-2032
  • Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2010-2024

R&D ecosystem & company landscape

6
  • Premium Statistic Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
  • Basic Statistic Pharma companies worldwide with active R&D pipelines 2001-2026
  • Premium Statistic Distribution of pharmaceutical R&D companies by region 2025 vs. 2026
  • Premium Statistic R&D spending share of top pharmaceutical companies 2024
  • Basic Statistic Major pharmaceutical companies in R&D spending growth in 2024
  • Premium Statistic Top pharma companies worldwide 2026, by size of R&D pipeline

R&D pipeline size and top assets

4
  • Premium Statistic Number of drugs in the R&D pipeline worldwide 2001-2026
  • Basic Statistic Drugs in R&D pipeline worldwide 2025-2026, by phase of development
  • Premium Statistic Pharmaceutical industry - number of new substances 1998-2025
  • Basic Statistic Projected most valuable R&D projects based on net present value 2026

Characteristics of R&D pipeline

5
  • Basic Statistic Top therapeutic categories worldwide 2026, by number of R&D products
  • Premium Statistic Worldwide top diseases 2026, by number of drugs in R&D
  • Basic Statistic Worldwide major types for pipeline drugs by number of active drugs 2026
  • Basic Statistic Worldwide pipeline drugs by delivery route share 2025 vs. 2026
  • Basic Statistic Worldwide top drug-producing mechanisms of action by number of active compounds 2026

Duration, cost and ROI

7
  • Basic Statistic Average length of a clinical trial cycle 2020-2024
  • Premium Statistic U.S. drug development phase success rates 2011-2020
  • Premium Statistic Clinical trial success rates by therapeutic area 2020
  • Premium Statistic Clinical trial LoA of top pharma companies 2006-2022
  • Premium Statistic Average R&D cost to develop new biopharma compound 2013-2025
  • Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2025
  • Basic Statistic Rate of return on biopharma R&D late-stage pipeline 2013-2025

Outsourced R&D

6
  • Basic Statistic CRO market size worldwide forecast 2032
  • Premium Statistic Leading global contract research organizations 2025, based on revenue
  • Premium Statistic CDMO market size worldwide forecast 2025-2034
  • Basic Statistic Leading pharma contract development and manufacturing companies 2024
  • Premium Statistic Likelihood of outsourcing drug development activities by biopharma companies 2025
  • Premium Statistic Outsourcing in clinical development among global biopharma companies by size 2025
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.